期刊文献+

人组织激肽释放酶的神经保护作用 被引量:4

Neuroprotective Effects of Human Tissue Kallikrein
原文传递
导出
摘要 大量临床和实验研究提示,人组织激肽释放酶(HTK)具有神经保护作用,如扩张脑动脉、促进缺血脑内新血管形成、促进神经胶质细胞迁移、抑制细胞凋亡、减少炎症细胞浸润等。基因敲除和转基因模型的建立进一步扩大了对HTK研究的深度和广度,为缺血性脑血管病的治疗和新药开发提供了广阔的前景。 A large number of clinical and experimental studies have suggested that the human tissue kallikrein (HTK) has the effects of neuroprotection, such as dilating brain arteries, enhancing neovascularization in ischemic brain, promoting neuroglial cell migration, inhibiting apoptosis, and reducing inflammatory cell infiltration, etc. The establishment of gene knockout and transgenic animal models has further extended the depth and scope of the HTK study, which provides a broad prospect for the treatment of ischemic cerebrovascular disease and dexelopment of new medications.
出处 《国际脑血管病杂志》 2007年第9期678-681,共4页 International Journal of Cerebrovascular Diseases
关键词 人组织激肽释放酶 激肽 脑缺血 human tissue kallikrein kinin cerebral ischemia
  • 相关文献

参考文献28

  • 1Harvey TJ, Hooper JD, Myers SA, et al. Tissue-specific expression parterre and fine mapping of the human kallikrein (KLK) locus on proximal 19q13. 4. J Biol Chem, 2000, 275:37397 - 37406.
  • 2Chao J, Chao L. Kallikrein-kinin in stroke, cardiovascular and renal disease. Exp Physiol, 2005, 90:291 -298.
  • 3汪涛,康毅,娄建石.激肽释放酶-激肽系统的心血管领域研究进展[J].中国药理学与毒理学杂志,2003,17(6):466-470. 被引量:26
  • 4井明艳,孙建义.激肽释放酶的研究进展[J].中国抗生素杂志,2005,30(3):187-192. 被引量:4
  • 5杨剑辉,孟建中.激肽释放酶激肽系统与高血压[J].国外医学(泌尿系统分册),2003,23(6):765-768. 被引量:6
  • 6Marcondes S, Antunes E.The plasma and tissue kininogen-kallikrein-kinin system: role in the cardiovascular system. Curr Med Chem Cardiovasc Hematol Agents, 2005, 3:33 -44.
  • 7赵春霞,汪培华,李宏伟,Lee Chao,Julie Chao,肖啸,汪道文.果糖诱导大鼠胰岛素抵抗和高血压的机制及人组织型激肽释放酶基因的治疗作用[J].中华心血管病杂志,2003,31(10):756-761. 被引量:7
  • 8Xia CF, Yin H, Borlongan CV, et al. Kallikrein gene transfer protects against ischemic stroke by promoting glial cell migration and inhibiting apoptosis. Hypertension, 2004, 43 : 452 - 459.
  • 9Raidoo DM, Ramsaroop R, Naidoo S, et al. Regional distribution of tissue kallikrein in the human brain.Immunopharmacology, 1996, 32: 39 - 47.
  • 10Lumenta DB, Plesnila N, Klasner B, et al. Neuroprotective effects of a postischemic treatment with a bradykinin B2 receptor antagonist in a rat model of temporary focal cerebral ischemia. Brain Res, 2006, 1069: 227 - 234.

二级参考文献72

  • 1Erdos EG. Cardiovesc Res,2002;54(3) :485 ~ 91.
  • 2Marshall P, Heudi O, McKeown S, et al. Rapid Commun Mass Spectrorn,2002;16(3) :220~ 8.
  • 3Campbell DJ.Clin Exp Pharmacol Physiol,2001;28(12):1060 ~ 5.
  • 4Balment RJ, Masini MA, Vallarino M, et al. Comp Biochem Physiol A Mol Integr Physiol,2002; 131 (2) :467 ~ 74.
  • 5Patel A, Smith FG. Am J Physiol Regul Integr Comp Physiol, 2001 ; 281(4):R1311 ~ 8.
  • 6Majima M, Hayashi I,Inamura N,et al.Hypertension,2000;35:437~42.
  • 7Katori M,Majima M, Hayashi. Biol Res, 1998;31(3) : 143 ~ 9.
  • 8Rhaleb NE, Yang XP,Nanba M,et al. Hypertension,2001 ;37(1 ) : 121 ~128.
  • 9Pastaldo R, Paolocci N,Chiribiri A,et al.Am J Physiol Heart Circ Physiol,2001 ;280(6) : H2823 ~ 32.
  • 10Tornel J,Madrid MI,Garcia-Salom M,et al. Circ Res,2000;86(5):589~95.

共引文献35

同被引文献90

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部